Enter assignee name

EPO Patents = 1

Trademarks = 7

Forward Citations = 26

Loading Chart...

6 inventors (with patents filed for the assignee):

Douglas Michael Ackermann, Jr (8 out of 36 patents)

Bobak Robert Azamian (8 out of 35 patents)

Shawn D Hickok (8 out of 8 patents)

4. Joseph G Vehige (8 out of 8 patents)

5. Tiang Hin Jerry Tan (1 out of 1 patent)

6. Yong Ming Por (1 out of 1 patent)

7. Douglas Michael Ackermann (34 patents)

9 patents: Sort by Forward Citations

1. 12364685 - Isoxazoline parasiticide formulations (2025-07-22),

2. 12257263 - Pharmaceutical compositions for demodex related blepharitis and eyelid crusting (2025-03-25),

3. 12213964 - Isoxazoline parasiticide formulations (2025-02-04),

4. 12171750 - Isoxazoline parasiticide formulations and methods for treating blepharitis (2024-12-24),

5. 11752137 - Ophthalmic compositions for treating ocularusing lotilaner formulations (2023-09-12),

6. 11690827 - Methods for treating ocularusing lotilaner formulations (2023-07-04),

7. 11690826 - Methods for treating demodex blepharitis using lotilaner formulations (2023-07-04),

8. 11197847 - Isoxazoline parasiticide formulations and methods for treating blepharitis (2021-12-14),

9. 10835517 - Methods for treating ocular demodex using isoxazoline parasiticide formulations (2020-11-17),

Tarsus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing novel treatments for patients with eye diseases. The company's innovative pipeline includes potential therapies for conditions such as dry eye disease and meibomian gland dysfunction. Tarsus is dedicated to improving the quality of life for individuals suffering from these debilitating eye conditions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

9 Patents

#303 in Irvine, CA

#7,496 in California

#31,619 in US

Irvine, CA, United States of America

Tarsus Pharmaceuticals, Inc.